Author

J. Savage

Institution: Apellis Pharmaceuticals (United States)

Observed institution: Apellis Pharmaceuticals (United States)

OpenAlex ID: A5015734031

P839: Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Pegcetacoplan Show Improvements in D-dimer Normalization and Decrease in Incidence of Thrombosis

2022 · I. Weitz, M. Al-Adhami, et al. · HemaSphere · 6

S303: Effect of Pegcetacoplan on Quality of Life in Complement-inhibitor Naïve Patients With Paroxysmal Nocturnal Hemoglobinuria: Results From the Phase 3 Prince Study

2022 · D. Gomez-Almaguer, R. Wong, et al. · HemaSphere · 3

Works count: 2

Citation count: 9

H-index: 2

I10-index: